Early Phase 1 Thalassemia Clinical Trials
3 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–3 of 3 trials
Recruiting
Early Phase 1
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
Sickle Cell DiseaseThalassemiaHemoglobinopathy
National Heart, Lung, and Blood Institute (NHLBI)100 enrolled1 locationNCT06313398
Recruiting
Early Phase 1
Safety and Efficacy of RM-004 Cells for Hemoglobin H-Constant Spring Disease
Hereditary DiseasesHemoglobinopathiesAlpha Thalassemia Hemoglobin H Constant Spring
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army5 enrolled1 locationNCT06107400
Recruiting
Early Phase 1
A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]
Transfusion Dependent Beta-Thalassemia
First Affiliated Hospital of Guangxi Medical University5 enrolled1 locationNCT05762510